Found: 24
Select item for more details and to access through your institution.
Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Statins and the Squalene Synthase Inhibitor Zaragozic Acid Stimulate the Non-Amyloidogenic Pathway of Amyloid-β Protein Precursor Processing by Suppression of Cholesterol Synthesis.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 20, n. 4, p. 1215, doi. 10.3233/JAD-2010-091621
- By:
- Publication type:
- Article
Regulated Proteolysis of RAGE and AβPP as Possible Link Between Type 2 Diabetes Mellitus and Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 4, p. 865, doi. 10.3233/JAD-2009-0998
- By:
- Publication type:
- Article
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
- Published in:
- Journal of Clinical Investigation, 2004, v. 113, n. 10, p. 1456, doi. 10.1172/JCI200420864
- By:
- Publication type:
- Article
Dissecting the role of ADAM10 as a mediator of Staphylococcus aureus α-toxin action.
- Published in:
- Biochemical Journal, 2016, v. 473, n. 13, p. 1929, doi. 10.1042/BCJ20160062
- By:
- Publication type:
- Article
P4-256: PACAP peptides as new α-secretase activators
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P4-256: PACAP peptides as new α-secretase activators
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Alpha-secretase as a therapeutic target
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases.
- Published in:
- FEBS Journal, 2005, v. 272, n. 22, p. 5808, doi. 10.1111/j.1742-4658.2005.04976.x
- By:
- Publication type:
- Article
Amphiphilic Copolymers Shuttle Drugs Across the Blood-Brain Barrier.
- Published in:
- Macromolecular Bioscience, 2016, v. 16, n. 5, p. 655, doi. 10.1002/mabi.201500388
- By:
- Publication type:
- Article
Synthesis of Maleimide-Functionalyzed HPMA-Copolymers and in vitro Characterization of the aRAGE- and Human Immunoglobulin (huIgG)-Polymer Conjugates.
- Published in:
- Macromolecular Bioscience, 2013, v. 13, n. 2, p. 203, doi. 10.1002/mabi.201200344
- By:
- Publication type:
- Article
Induction of RAGE Shedding by Activation of G Protein-Coupled Receptors.
- Published in:
- PLoS ONE, 2012, v. 7, n. 7, p. 1, doi. 10.1371/journal.pone.0041823
- By:
- Publication type:
- Article
α-Secretase Activation – An Approach to Alzheimer’s Disease Therapy.
- Published in:
- Neurodegenerative Diseases, 2006, v. 3, n. 4/5, p. 255, doi. 10.1159/000095264
- By:
- Publication type:
- Article
α-Secretase Activity of the Disintegrin Metalloprotease ADAM 10: Influences of Domain Structure.
- Published in:
- Annals of the New York Academy of Sciences, 2000, v. 920, n. 1, p. 215, doi. 10.1111/j.1749-6632.2000.tb06925.x
- By:
- Publication type:
- Article
Differential gene expression in ADAM10 and mutant ADAM10 transgenic mice.
- Published in:
- BMC Genomics, 2009, v. 10, p. 1, doi. 10.1186/1471-2164-10-66
- By:
- Publication type:
- Article
Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
- Published in:
- FASEB Journal, 2014, v. 28, n. 2, p. 978, doi. 10.1096/fj.13-234864
- By:
- Publication type:
- Article
Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.
- Published in:
- FASEB Journal, 2011, v. 25, n. 9, p. 3208, doi. 10.1096/fj.10-180133
- By:
- Publication type:
- Article
Crosstalk between angiotensin and the nonamyloidogenic pathway of Alzheimer's amyloid precursor protein.
- Published in:
- FEBS Journal, 2017, v. 284, n. 5, p. 742, doi. 10.1111/febs.14015
- By:
- Publication type:
- Article
The neuropeptide PACAP promotes the α-secretase pathway for processing the Alzheimer amyloid precursor protein.
- Published in:
- FASEB Journal, 2006, v. 20, n. 3, p. 512, doi. 10.1096/fj.05-4812fje
- By:
- Publication type:
- Article
Genomic structure and functional characterization of the human ADAM10 promoter.
- Published in:
- FASEB Journal, 2005, v. 19, n. 11, p. 1522, doi. 10.1096/fj.04-3619fje
- By:
- Publication type:
- Article
Activation of α-secretase cleavage.
- Published in:
- Journal of Neurochemistry, 2012, v. 120, p. 46, doi. 10.1111/j.1471-4159.2011.07459.x
- By:
- Publication type:
- Article
The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin β and ADAM10.
- Published in:
- Cellular & Molecular Life Sciences, 2013, v. 70, n. 2, p. 309, doi. 10.1007/s00018-012-1106-2
- By:
- Publication type:
- Article
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease.
- Published in:
- Cellular & Molecular Life Sciences, 2009, v. 66, n. 24, p. 3923, doi. 10.1007/s00018-009-0121-4
- By:
- Publication type:
- Article
Melatonin stimulates the nonamyloidogenic processing of β APP through the positive transcriptional regulation of ADAM10 and ADAM17.
- Published in:
- Journal of Pineal Research, 2015, v. 58, n. 2, p. 151, doi. 10.1111/jpi.12200
- By:
- Publication type:
- Article